Docusate Sodium Capsule, Liquid Filled
Product Images NDC 53345-035

1 FDA label image from Humanwell Puracap Pharmaceuticals (wuhan) Co., Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 53345-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Humanwell Puracap Pharmaceuticals (wuhan) Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dss 250 mg Bulk Label

Dss 250 mg Bulk Label
Packaging label for Docusate Sodium Capsules 250 mg by Humanwell PuraCap Pharmaceutical (Wuhan) Ltd. The label specifies the product as softgel capsules containing 250 mg Docusate Sodium each, with a bulk quantity of 7000 capsules. It includes handling instructions and manufacturing details, indicating origin in China.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.